MetaCap

Kardigan Inc. (KARD)

NASDAQ: KARDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.54-0.98 (-7.83%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

KARD stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$6.24
52-week range
11.49 – 27.00
Day range
11.49 – 12.77
Volume / Avg
459.24K / 625.83K
Beta
—

52-week range

$11.49$27.00

KARD stock today

Shares of Kardigan (KARD) finished lower on Nov 20 at $11.54, a drop of 7.83% or $0.98 per share, versus the S&P 500's 3.70% decline. At this level, KARD sits near the bottom of its 52-week range of $11.49 to $27.00: 57.3% below the high, set on Jun 29, 2026 and 0.4% above the low. Kardigan has posted a net loss over the last twelve months (EPS of -$6.24), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Kardigan

Company profile

Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Tassos Anastasios E. Gianakakos M.Sc., MBA
Headquarters
Princeton, NJ
Employees
241
IPO year
2026

Analyst forecast

Forecast

Consensus (9 analysts)

strong_buy

Avg. price target

$41.00+255.29%

  • Strong buy 1
  • Buy 8
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $25.00High $50.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$-0.64 vs $-0.80
Surprise
+20.00%

KARD news

All KARD news

Kardigan peers

Health Care sector
KARD peer companies
CompanyPrice% ChgMarket capCompare
JBIOJade Biosciences Inc.15.31+1.66%$1.06Bvs KARD
AAPGAscentage Pharma Group International American Depository Shares11.97-3.78%$1.12Bvs KARD
NKTRNektar Therapeutics30.20-7.19%$1.03Bvs KARD
CTYCity Therapeutics Inc.19.32+5.29%$1.03Bvs KARD
CMPSCOMPASS Pathways Plc American Depository Shares8.05-6.94%$1.14Bvs KARD
HROWHarrow Inc.30.41-5.35%$1.14Bvs KARD
ANROAlto Neuroscience Inc.25.37-4.30%$1.02Bvs KARD
GPCRStructure Therapeutics Inc. ADR16.13-5.78%$1.15Bvs KARD

Indexes, lists and sector

Kardigan stock FAQ

What is Kardigan's stock price today?

KARD last traded at $11.54 as of Nov 20, 4:00 PM EST, down 7.83% on the day. Prices are delayed at least 15 minutes.

Who is Kardigan's CEO?

Mr. Tassos Anastasios E. Gianakakos M.Sc., MBA is the chief executive officer of Kardigan Inc., which has about 241 employees.

What is the KARD 52-week high?

The 52-week high for KARD is $27.00 and the 52-week low is $11.49. The stock is currently 57.3% below its high.

Compare KARD